Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A46692 | 16489319 | Panminerva Med | Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. | 2005 | Details |
| A46698 | 16444867 | Vasc Med | Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. | 2005 | Details |
| A46706 | 16340637 | J Clin Gastroenterol | Liver disease in patients with diabetes mellitus. | 2006 | Details |
| A46762 | 15779390 | Nihon Rinsho | [Impaired glucose tolerance in nonalcoholic fatty liver disease]. | 2005 | Details |
| A46781 | 15611492 | Ann Intern Med | Narrative review: hepatobiliary disease in type 2 diabetes mellitus. | 2004 | Details |
| A46788 | 15547646 | Angiology | Prevention and treatment of the metabolic syndrome. | 2005 | Details |
| A46802 | 15262299 | Endocrinol Metab Clin North Am | Glitazones and the management of insulin resistance: what they do and how might they be used. | 2004 | Details |
| A46817 | 14749503 | Recent Prog Horm Res | Obesity, insulin resistance, and cardiovascular disease. | 2004 | Details |
| A46953 | 32749590 | Eur Radiol | Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study. | 2020 | Details |
| A46977 | 31493100 | Wien Klin Wochenschr | Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver disease. | 2019 | Details |
| A47238 | 21819471 | Addiction | Alcohol consumption and non-communicable diseases: epidemiology and policy implications. | 2011 | Details |
| A47296 | 18541827 | Arch Intern Med | Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. | 2008 | Details |
| A47602 | 35222273 | Front Endocrinol (Lausanne) | The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases. | 2022 | Details |
| A47613 | 35069833 | Exp Ther Med | Cardiovascular comorbidities in psoriasis (Review). | 2021 | Details |
| A47634 | 34535788 | Nat Rev Drug Discov | Emerging therapeutic opportunities for integrin inhibitors. | 2021 | Details |
| A47676 | 33839215 | Food Chem Toxicol | Fasting-mediated metabolic and toxicity reprogramming impacts circulating microRNA levels in humans. | 2021 | Details |
| A47678 | 33825142 | J Nucl Cardiol | Cardiac imaging for the assessment of patients being evaluated for liver transplantation. | 2021 | Details |
| A47683 | 33750661 | J Cardiothorac Vasc Anesth | Machine Learning Models to Predict Major Adverse Cardiovascular Events After Orthotopic Liver Transplantation: A Cohort Study. | 2021 | Details |
| A47698 | 33533556 | Liver Transpl | Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria. | 2021 | Details |
| A47717 | 33082899 | Radiol Case Rep | A case report of constrictive pericarditis: a forgotten cause of refractory ascites. | 2020 | Details |
| A47728 | 32830851 | J Clin Endocrinol Metab | Identification of Proteins Associated with the Early Restoration of Insulin Sensitivity After Biliopancreatic Diversion. | 2020 | Details |
| A47739 | 32680936 | Diabetes | Simultaneous Inhibition of Peripheral CB1R and iNOS Mitigates Obesity-Related Dyslipidemia Through Distinct Mechanisms. | 2020 | Details |
| A47803 | 31584469 | Cardiol Rev | Cardiovascular Risk Assessment in Renal and Liver Transplant Candidates: A Multidisciplinary Institutional Standardized Approach. | 2020 | Details |
| A47837 | 31144046 | Handb Exp Pharmacol | Targeting Bile Acid-Activated Receptors in Bariatric Surgery. | 2019 | Details |
| A47858 | 30742277 | Drugs | The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus. | 2019 | Details |
| A47860 | 30720567 | J Thorac Imaging | Noncontrast Chest Computed Tomographic Imaging of Obesity and the Metabolic Syndrome: Part II Noncardiovascular Findings. | 2019 | Details |
| A47863 | 30672598 | Hepatology | Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events in Liver Transplant Recipients. | 2019 | Details |
| A47884 | 30072250 | Surgery | Early mortality after liver transplantation: Defining the course and the cause. | 2018 | Details |
| A47889 | 30004270 | J Laparoendosc Adv Surg Tech A | Preoperative Evaluation in Bariatric Surgery. | 2018 | Details |
| A47896 | 29870275 | Diabetes Technol Ther | The Clinical Impact of GLP-1 Receptor Agonists in Type 2 Diabetes: Focus on the Long-Acting Analogs. | 2018 | Details |
| A47899 | 29749243 | Bratisl Lek Listy | The predictive value of risk indices for cardiac complications in living donor liver transplantation. | 2019 | Details |
| A47935 | 28847797 | Circulation | Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors. | 2017 | Details |
| A47960 | 28098353 | J Cell Physiol | The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice. | 2017 | Details |
| A48016 | 26486483 | Vnitr Lek | [Polycystic ovary syndrome]. | 2015 | Details |
| A48040 | 25904829 | Gastroenterol Hepatol (N Y) | Effects of statins on the risk of hepatocellular carcinoma. | 2014 | Details |
| A48055 | 25498545 | Biochem Biophys Res Commun | Betaine is a positive regulator of mitochondrial respiration. | 2014 | Details |
| A48068 | 25213120 | Liver Transpl | Adverse cardiac events after orthotopic liver transplantation: a cross-sectional study in 389 consecutive patients. | 2015 | Details |
| A48083 | 24602085 | Ann N Y Acad Sci | Gastrointestinal morbidity in obesity. | 2014 | Details |
| A48084 | 24595862 | Eur J Prev Cardiol | Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris. | 2014 | Details |
| A48090 | 24380645 | Metab Syndr Relat Disord | Metabolic syndrome prevalence and associations in a bariatric surgery cohort from the Longitudinal Assessment of Bariatric Surgery-2 study. | 2013 | Details |
| A48096 | 23974764 | Curr Opin Endocrinol Diabetes Obes | A complications-based clinical staging of obesity to guide treatment modality and intensity. | 2013 | Details |
| A48098 | 26201809 | Hepatol Int | Ethnicity predicts metabolic syndrome after liver transplant. | 2012 | Details |
| A48127 | 22333480 | J Pharmacol Sci | Multiple mechanisms for the action of chymase inhibitors. | 2012 | Details |
| A48129 | 22248781 | Pediatr Endocrinol Diabetes Metab | [Insulin resistance in children]. | 2011 | Details |
| A48168 | 20843257 | N Engl J Med | Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. | 2010 | Details |
| A48319 | 16772767 | Am J Ther | Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk. | 2006 | Details |
| A48322 | 16617233 | Am J Med Sci | The effect of obesity surgery on obesity comorbidity. | 2006 | Details |
| A48325 | 16522283 | Curr Diab Rep | Metabolic syndrome in the elderly. | 2006 | Details |
| A48549 | 34267725 | Front Endocrinol (Lausanne) | Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide. | 2021 | Details |
| A48558 | 34137731 | Endocr Connect | How glucagon-like peptide 1 receptor agonists work. | 2021 | Details |
| A48573 | 33815359 | Front Immunol | Adipocyte Fatty Acid-Binding Protein, Cardiovascular Diseases and Mortality. | 2021 | Details |
| A48606 | 33193106 | Front Endocrinol (Lausanne) | A Comprehensive Update on the Chylomicronemia Syndrome. | 2020 | Details |
| A48609 | 33158470 | Best Pract Res Clin Gastroenterol | Cardiovascular and metabolic disease in the liver transplant recipient. | 2020 | Details |
| A48617 | 32918343 | Helicobacter | Review: Extragastric diseases and Helicobacter pylori. | 2020 | Details |
| A48618 | 32903449 | Front Pharmacol | Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities. | 2020 | Details |
| A48620 | 32865979 | Biochemistry | Hepatocellular Carcinoma and Statins. | 2020 | Details |
| A48639 | 32592089 | J Physiol Biochem | Lactosylceramide induced by elastin-derived peptides decreases adipocyte differentiation. | 2020 | Details |
| A48641 | 32582143 | Front Immunol | The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. | 2020 | Details |
| A48722 | 30691442 | BMC Pediatr | Bariatric surgery in adolescents: a prospective randomized controlled trial comparing laparoscopic gastric banding to combined lifestyle interventions in adolescents with severe obesity (BASIC trial). | 2019 | Details |
| A48745 | 29935912 | Diabetes Res Clin Pract | Corrigendum to "An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis" [Diab. Res. Clin. Pract. 135 (2018) 102-110]. | 2018 | Details |
| A48751 | 29751356 | Clin Exp Pharmacol Physiol | Exploring novel pharmacotherapeutic applications and repurposing potential of sodium glucose CoTransporter 2 inhibitors. | 2018 | Details |
| A48758 | 29519261 | Ned Tijdschr Geneeskd | [EndoBarrier as a treatment for obesity and diabetes]. | 2018 | Details |
| A48805 | 30802391 | Klin Lab Diagn | [The chronic hepatitis under pulmonary, extra-pulmonary and abdominal tuberculosis.] | 2019 | Details |
| A48821 | 27618008 | Int J Mol Sci | Physiological and Pathogenic Roles of Prolyl Isomerase Pin1 in Metabolic Regulations via Multiple Signal Transduction Pathway Modulations. | 2016 | Details |
| A48844 | 26763484 | Liver Int | Chronic hepatitis C virus infection, a new cardiovascular risk factor? | 2016 | Details |
| A48850 | 26680665 | Physiol Res | Fasting and nonfasting triglycerides in cardiovascular and other diseases. | 2015 | Details |
| A48906 | 24838495 | Dig Dis Sci | Statin use in patients with cirrhosis: a retrospective cohort study. | 2014 | Details |
| A48931 | 24119080 | Acta Physiol (Oxf) | Lipotoxicity and the role of maternal nutrition. | 2013 | Details |
| A48940 | 23768554 | Best Pract Res Clin Gastroenterol | Diabetes, obesity and gut microbiota. | 2013 | Details |
| A48947 | 23515103 | Clin Chem Lab Med | Gender medicine: a task for the third millennium. | 2013 | Details |
| A48965 | 22959954 | Prostaglandins Leukot Essent Fatty Acids | Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. | 2012 | Details |
| A48972 | 22721876 | Nutrition | Caffeine attenuates metabolic syndrome in diet-induced obese rats. | 2012 | Details |
| A49014 | 21329483 | Scand J Urol Nephrol | Management of diuretic treatment: a challenge in the obese patient. | 2011 | Details |
| A49031 | 20716942 | Oxid Med Cell Longev | Acetaldehyde adducts in alcoholic liver disease. | 2010 | Details |
| A49068 | 19415399 | J Gastrointest Surg | Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation. | 2009 | Details |
| A49070 | 19255916 | Crit Rev Clin Lab Sci | The paraoxonases: role in human diseases and methodological difficulties in measurement. | 2009 | Details |
| A49071 | 19250782 | Gastroenterol Clin Biol | [Review of the association between obesity and gastroesophageal reflux and its complications]. | 2009 | Details |
| A49090 | 18400637 | Anadolu Kardiyol Derg | [Global confusion on the diagnostic criteria for metabolic syndrome: what is the point that guidelines can not agree?]. | 2008 | Details |
| A49117 | 17058987 | Rev Gastroenterol Mex | [Ghrelin: beyond hunger regulation]. | 2006 | Details |
| A49150 | 16208305 | Minerva Endocrinol | The metabolic syndrome and type 2 diabetes. | 2005 | Details |
| A49185 | 15040152 | Vnitr Lek | [The metabolic syndrome]. | 2003 | Details |
| A49217 | 35819592 | Pharmacol Rep | Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5/Dmcr rat via acceleration of abnormal lipid metabolism. | 2022 | Details |
| A49223 | 35817047 | Exp Clin Endocrinol Diabetes | Comorbidities in Mild Autonomous Cortisol Secretion - A Clinical Review of Literature. | 2022 | Details |
| A49243 | 35811725 | Front Cardiovasc Med | Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) - Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease. | 2022 | Details |
| A49244 | 35811662 | Dis Markers | Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A49252 | 35809408 | Comput Biol Med | In silico and in vitro analysis of PPAR - α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat. | 2022 | Details |
| A49268 | 35806300 | Int J Mol Sci | Different Metabolism and Toxicity of TRANS Fatty Acids, Elaidate and Vaccenate Compared to Cis-Oleate in HepG2 Cells. | 2022 | Details |
| A49317 | 35790023 | Diabet Med | Banting Memorial lecture 2022: 'Type 2 diabetes and nonalcoholic fatty liver disease: partners in crime'. | 2022 | Details |
| A49318 | 35790018 | Hepatology | Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease. | 2022 | Details |
| A49327 | 35787557 | Chin Med J (Engl) | Retinol-binding protein-4 and nonalcoholic fatty liver disease. | 2022 | Details |
| A49328 | 35787436 | Food Chem Toxicol | The hypolipidemic, anti-inflammatory and antioxidant effect of Kavolì® aqueous extract, a mixture of Brassica oleracea leaves, in a rat model of NAFLD. | 2022 | Details |
| A49340 | 35783879 | Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease. | 2022 | Details |
| A49351 | 35780909 | Metabolism | Time to transition from a negative nomenclature describing what NAFLD is not, to a novel, pathophysiology-based, umbrella classification of fatty liver disease (FLD). | 2022 | Details |
| A49356 | 35779422 | Biomed Pharmacother | Recent advances in lean NAFLD. | 2022 | Details |
| A49360 | 35778847 | Lipids | Structurally-engineered fatty acid 1024 (SEFA-1024) improves diet-induced obesity, insulin resistance, and fatty liver disease. | 2022 | Details |
| A49382 | 35768242 | Endocr J | Trends in the high blood glucose and non-alcoholic fatty liver disease among Korean adolescents. | 2022 | Details |
| A49418 | 35757255 | Front Nutr | Curcuminoids for Metabolic Syndrome: Meta-Analysis Evidences Toward Personalized Prevention and Treatment Management. | 2022 | Details |
| A49421 | 35757147 | Int J Cardiol Heart Vasc | Synergistic effects of liver fibrosis and sarcopenia on endothelial dysfunction and arterial stiffness in patients with type 2 diabetes. | 2022 | Details |
| A49447 | 35747175 | EClinicalMedicine | The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy. | 2022 | Details |
| A49457 | 35745097 | Nutrients | Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002-2012). | 2022 | Details |